Correlation Engine 2.0
Clear Search sequence regions

  • apoptosis (2)
  • CASP3 (1)
  • CASP7 protein (1)
  • cell death (1)
  • cell numbers (1)
  • fibroblasts (6)
  • gingiva (1)
  • human (6)
  • necrosis (2)
  • oral cancer (1)
  • oxygen (4)
  • protein human (2)
  • smoke (9)
  • species (4)
  • tobacco (1)
  • vapor (9)
  • Sizes of these terms reflect their relevance to your search.

    Human gingival fibroblasts (HGF) play a vital role in wound healing, oral cancer, and are among the first cells being exposed to e-cigarette vapor (eCV) or cigarette smoke (CS) during inhalation. Although the cell-damaging effect of CS has been well studied, the effects of eCV on gingival cells are still unclear. The aim of this in vitro study was to compare the effects of eCV and CS on HGF in terms of proliferation, metabolic activity, cell death, and formation of reactive oxygen species (ROS). After 24 h cell numbers in CS-exposed cells in contrast to eCV-exposed cells were significantly decreased compared to the control. At later points in time, such differences could no longer be observed. Compared to the control, HGF stimulated with eCV showed a significantly higher metabolic activity 1 h, 24 h, and 48 h after exposure. 24 h after exposure, the metabolic activity was increased in both test groups. No caspase 3/7 activation nor significant differences in the amount of apoptosis/necrosis among the groups were seen. Only in CS-exposed cells ROS formation was increased at 1 h, 3 h, and 6 h after exposition. In conclusion, when compared to conventional CS, a less harmful effect of eCV on HGF can be assumed. Copyright © 2020 Elsevier Ltd. All rights reserved.


    M F Vermehren, N Wiesmann, J Deschner, J Brieger, B Al-Nawas, P W Kämmerer. Comparative analysis of the impact of e-cigarette vapor and cigarette smoke on human gingival fibroblasts. Toxicology in vitro : an international journal published in association with BIBRA. 2020 Dec;69:105005

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 32956835

    View Full Text